Researchers awarded $2.4 million for brain artery health studies

(University of Tennessee Health Science Center) Alex Dopico, MD, PhD, professor and Van Vleet Chair of Excellence in the Department of Pharmacology, Addiction Science, and Toxicology, and Anna Bukiya, PhD, associate professor in the Department of Pharmacology, Addiction Science, and Toxicology, have been awarded $2.4 million from the National Heart, Lung, and Blood Institute (NHLBI) to explore how cholesterol interacts with the mechanisms that modulate blood vessel function in the brain.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

CONCLUSION: Dyslipidemia, oxidant-stress in association with T3 augment cardiac-pathogenesis. PMID: 32940193 [PubMed - as supplied by publisher]
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Endocrinology Authors: Tags: Endocr Metab Immune Disord Drug Targets Source Type: research
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out m...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
I wanted to see if anyone had heard of the link between LDL, TGs, and French press coffee. I don’t think it’s been well studied but there are some hints out there that it’s a real thing. My own panel showed a significant drop after completely switching to filtered drip. I drink probably 3/4 gallon of coffee daily, many press drinkers are in that category of addict as well. This might sound trivial, but I’m seriously considering including it among counseling points for statin patients. Anyone... French press and cholesterol
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pharmacy Source Type: forums
In the fall of 2019, my hospital put out word that it was looking for physicians who might wish to undergo intensive training to become certified health and wellness coaches. Having worked with patients who have used health coaching, I jumped at the chance. Their experiences were almost universally positive: many of them had attained health goals that had been otherwise elusive, such as the weight loss they invoked annually — and fruitlessly — as a New Year’s resolution. The few physicians I knew who were also coaches seemed to be able to fuse the different skill sets in a way that expanded their ability ...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Behavioral Health Exercise and Fitness Healthy Eating Mind body medicine Nutrition Prevention Stress Source Type: blogs
AbstractThe present study was undertaken to evaluate lipid profile in tobacco consumers with and without head and neck malignancy and to see whether tobacco consumption causes same degree of alteration in lipid profile. Prospective study of serum lipid profile in 90 patients was done at Govt. Medical College Hospital. Various details of all participants such as age and sex of patients, detailed history of tobacco consumption were taken. Patients were divided into group I, II and III. Serum lipid profile was studied in 30 patients with tobacco addicts for more than 5  years in the form of tobacco chewing and smoking wi...
Source: Indian Journal of Otolaryngology and Head and Neck Surgery - Category: ENT & OMF Source Type: research
Publication date: Available online 14 November 2019Source: Journal of Pharmacological SciencesAuthor(s): Mitsuhisa Koga, Yuki Kanaoka, Mana Okamoto, Yuki Nakao, Koshun Inada, Saki Takayama, Yasufumi Kataoka, Atsushi YamauchiAbstractVarenicline is a widely used and effective drug for smoking cessation. We previously reported that varenicline aggravates atherosclerosis in apolipoprotein E knockout (ApoE KO) mice. However, it remains unknown whether varenicline affects cardiovascular events in patients with nicotine addiction. Here, we examined the effect of varenicline on atherosclerotic plaque formation in nicotine-pretreat...
Source: Journal of Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research
In this study, the prevalence of FA was 26.2% in women with obesity. In comparison with class I obesity, the odds ratios (95% CI) of FA for class II and class III obesity were 2.5 (CI: 1.29-5.09) and 3.3 (CI: 1.69-6.4) respectively. Dietary intakes of energy, protein, carbohydrate, fat, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, and cholesterol were significantly higher in food-addicted (FAD) women compared to non-food-addicted (NFA) ones (p 
Source: Peptides - Category: Biochemistry Source Type: research
Authors: Barton BB, Zagler A, Engl K, Rihs L, Musil R Abstract The information on prevalence of obesity, diabetes, metabolic syndrome (MetS) and cardiovascular risk (CVR) and on sociodemographic variables available in patients with psychiatric diseases about to be treated with weight gain-associated medication (e.g., clozapine, mirtazapine, quetiapine) is limited. In a naturalistic study, psychiatric inpatients (age: 18-75) of all F diagnoses according to ICD-10, who were about to be treated with weight gain-associated medication, were included. Demographic variables were assessed as well as biological parameters t...
Source: European Archives of Psychiatry and Clinical Neuroscience - Category: Psychiatry Tags: Eur Arch Psychiatry Clin Neurosci Source Type: research
AbstractThe information on prevalence of obesity, diabetes, metabolic syndrome (MetS) and cardiovascular risk (CVR) and on sociodemographic variables available in patients with psychiatric diseases about to be treated with weight gain-associated medication (e.g., clozapine, mirtazapine, quetiapine) is limited. In a naturalistic study, psychiatric inpatients (age: 18 –75) of all F diagnoses according to ICD-10, who were about to be treated with weight gain-associated medication, were included. Demographic variables were assessed as well as biological parameters to calculate the Body Mass Index (BMI), MetS, diabetes an...
Source: European Archives of Psychiatry and Clinical Neuroscience - Category: Neuroscience Source Type: research
More than half of new drugs entering the German healthcare system have not been shown to add benefit Related items fromOnMedica GPs defend practice on prescribing statins MHRA tightens licence restrictions on valproate for women Hunt announces Medicines and Medical Devices Safety Review Philip Morris knew nicotine is just one part of smoking addiction Antibiotics courses often longer than guidelines
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Addiction | Brain | Cardiology | Cholesterol | Drugs & Pharmacology | Heart | International Medicine & Public Health | Neurology | Science | Study | Toxicology